Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus (French, HTML)

View metadata and access the original French HTML file: Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus.

Format

HTML

Access

file-only

Publisher-reported update

2024-05-10

Health Canada carried out a safety review to assess the risk of birth defects with the use of ondansetron, as part of routine health product monitoring and because this drug is not authorized for sale in Canada to treat nausea and vomiting during pregnancy. The use of ondansetron during pregnancy is not recommended because its safety has not been established in pregnant women.

Access original file